<?xml version="1.0" encoding="utf-8"?>
<rr:ResultsReport>
	<rr:ResultsPayload>
		<FinalReport>
			<Sample>
				<FM_Id>AA -23-04122</FM_Id>
				<SampleId></SampleId>
				<BlockId>M112-10171_(PT23070)</BlockId>
				<TRFNumber></TRFNumber>
				<TestType></TestType>
				<SpecFormat>Lung  Type</SpecFormat>
				<ReceivedDate>Jun 26, 2023</ReceivedDate>
			</Sample>
			<PMI>
				<ReportId></ReportId>
				<MRN>45543042</MRN>
				<FullName>洪睿承</FullName>
				<FirstName></FirstName>
				<LastName></LastName>
				<SubmittedDiagnosis>Osteosarcoma</SubmittedDiagnosis>
				<Gender>Male</Gender>
				<DOB>Feb 21, 2007</DOB>
				<OrderingMD>顏秀如醫師</OrderingMD>
				<OrderingMDId></OrderingMDId>
				<Pathologist></Pathologist>
				<CopiedPhysician1></CopiedPhysician1>
				<MedFacilName>臺北榮總</MedFacilName>
				<MedFacilID></MedFacilID>
				<SpecSite></SpecSite>
				<CollDate></CollDate>
				<ReceivedDate></ReceivedDate>
				<CountryOfOrigin></CountryOfOrigin>
			</PMI>
		</FinalReport>
		<variant-report>
			<short_variants>
				<short_variant>
					<cds_effect>c.1759G&gt;T</cds_effect>
					<depth>1224</depth>
					<gene>ASXL1</gene>
					<percent_reads>14.3%</percent_reads>
					<protein_effect>G587C</protein_effect>
					<transcript>NM_015338</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.4057G&gt;A</cds_effect>
					<depth>518</depth>
					<gene>ATM</gene>
					<percent_reads>43.6%</percent_reads>
					<protein_effect>E1353K</protein_effect>
					<transcript>NM_000051</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.10C&gt;T</cds_effect>
					<depth>283</depth>
					<gene>AXL</gene>
					<percent_reads>98.2%</percent_reads>
					<protein_effect>R4W</protein_effect>
					<transcript>NM_021913</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.662C&gt;T</cds_effect>
					<depth>858</depth>
					<gene>BRD4</gene>
					<percent_reads>28.0%</percent_reads>
					<protein_effect>T221M</protein_effect>
					<transcript>NM_058243</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>42.7%</depth>
					<gene>EPHA2</gene>
					<percent_reads>-</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.1738+8G&gt;A</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.7010A&gt;G</cds_effect>
					<depth>823</depth>
					<gene>KMT2A</gene>
					<percent_reads>51.2%</percent_reads>
					<protein_effect>Q2337R</protein_effect>
					<transcript>NM_001197104</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1846G&gt;T</cds_effect>
					<depth>1415</depth>
					<gene>MAP3K1</gene>
					<percent_reads>28.1%</percent_reads>
					<protein_effect>G616W</protein_effect>
					<transcript>NM_005921</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1894A&gt;G</cds_effect>
					<depth>518</depth>
					<gene>MSH2</gene>
					<percent_reads>41.5%</percent_reads>
					<protein_effect>I632V</protein_effect>
					<transcript>NM_000251</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.3035C&gt;T</cds_effect>
					<depth>607</depth>
					<gene>PALB2</gene>
					<percent_reads>69.4%</percent_reads>
					<protein_effect>T1012I</protein_effect>
					<transcript>NM_024675</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1273G&gt;A</cds_effect>
					<depth>928</depth>
					<gene>PALB2</gene>
					<percent_reads>67.3%</percent_reads>
					<protein_effect>V425M</protein_effect>
					<transcript>NM_024675</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1932C&gt;G</cds_effect>
					<depth>922</depth>
					<gene>POLD1</gene>
					<percent_reads>50.3%</percent_reads>
					<protein_effect>D644E</protein_effect>
					<transcript>NM_001256849</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1186A&gt;G</cds_effect>
					<depth>1339</depth>
					<gene>PRKN</gene>
					<percent_reads>34.3%</percent_reads>
					<protein_effect>R396G</protein_effect>
					<transcript>NM_004562</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>46.8%</depth>
					<gene>PTCH1</gene>
					<percent_reads>-</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.2560+7C&gt;T</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.728A&gt;G</cds_effect>
					<depth>801</depth>
					<gene>RXRA</gene>
					<percent_reads>16.1%</percent_reads>
					<protein_effect>E243G</protein_effect>
					<transcript>NM_002957</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.583A&gt;G</cds_effect>
					<depth>55</depth>
					<gene>TSC2</gene>
					<percent_reads>71.6%</percent_reads>
					<protein_effect>I195V</protein_effect>
					<transcript>NM_000548</transcript>
				</short_variant>
			</short_variants>
			<copy_number_alterations>
				<copy_number_alteration>
					<copy_number>0</copy_number>
					<gene>TP53</gene>
					<position>Chr17</position>
					<type>Homozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>BRCA2</gene>
					<position>Chr13</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>PALB2</gene>
					<position>Chr16</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>STK11</gene>
					<position>Chr19</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>RAD50</gene>
					<position>Chr5</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>7</copy_number>
					<gene>KDR, KIT</gene>
					<position>Chr4</position>
					<type>Amplification</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>11</copy_number>
					<gene>CCNE1</gene>
					<position>Chr19</position>
					<type>Amplification</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>16</copy_number>
					<gene>PDGFRA</gene>
					<position>Chr4</position>
					<type>Amplification</type>
				</copy_number_alteration>
			</copy_number_alterations>
			<rearrangements>
			</rearrangements>
			<biomarkers>
				<microsatellite_instability>
					<status>Microsatellite stable (MSS)</status>
				</microsatellite_instability>
				<tumor_mutation_burden>
					<score>2.6</score>
				</tumor_mutation_burden>
			</biomarkers>
		</variant-report>
	</rr:ResultsPayload>
</rr:ResultsReport>